Bioabsorbable Fixation Implant Patents: Leaders & Trends 2026
Bioabsorbable Fixation Implant Patents: Who Holds the Core Claims
29.2% of all filings sit with just five assignees — the top 5 hold 112 of the 383 records in scope, against a long tail of single-filing entrants. Filings rose from 7 in 2017 to a peak of 35 in 2018. The 2021-to-2024 span shows a -36% change (22 down to 14), but 2025 and 2026 figures are still filling in under the usual 18-month publication lag, so treat the most recent two years as incomplete rather than as evidence of a continued decline.
- 1POSEIDON MEDICAL INC32
- 2STRYKER CORP30
- 3ABBOTT CARDIOVASCULAR SYSTEMS INC19
- 4TRICOL BIOMEDICAL INC16
- 5SPIROX INC15
See the full bioabsorbable fixation implants analysis in Eureka
- The complete ranking, not just the top five
- Every IPC branch with its share of the corpus
- The most-cited records, and where claim space is still thin
Common questions about bioabsorbable fixation implant patents
What patent classes cover bioabsorbable fixation implants?
The dominant classes in this dataset are A61L (sterilising and disinfecting), present on 53.0% of the 383 records in scope, and A61F (implants and prostheses), present on 45.2%. Smaller but distinct bands cover diagnosis and surgery methods (A61B, 22.7%), medicinal preparations (A61K, 10.7%), alloys (C22C, 6.5%), and polymer compositions (C08L, 6.3%). Because a single filing can carry several IPC codes, these percentages overlap rather than sum to 100%, and they reflect where claim activity actually clusters rather than a clean technology taxonomy.
Who are the leading filers in bioabsorbable fixation implants?
The ranked leaders in this dataset span 100 companies counted by record, with the top filer holding 32 records and the fifth-ranked holding 15. The top 5 filers combined account for 112 of the 383 records in scope, or 29.2%, and the top 10 account for 176, or 46.0% — meaning close to half the field’s activity sits with a small group, while the remainder is spread across a long tail of single- or few-filing entrants. This is a concentration pattern worth checking before assuming the field is wide open.
Is filing activity in bioabsorbable fixation implants growing or slowing?
Filings peaked at 35 in 2018 after starting at 7 in 2017, and the measurable recent trend shows a -36% change from 22 filings in 2021 to 14 in 2024. Because publication typically lags actual filing by roughly 18 months, the 2025 and 2026 figures in any dataset are still incomplete and should not be read as a continuing decline — they simply have not caught up yet. The safest reading is that the field has cooled from its 2018 peak but has not been characterized by data recent enough to call it dormant.
Disclaimer. This analysis is based on Patsnap Eureka data drawn from a limited snapshot of global patent records and is provided for general information and reference only. Patent data carries inherent limitations — recent filings are under-counted because of publication lag, counts may be on a record or family basis, classification and applicant-name data may contain errors or duplicates, and the underlying search query defines the scope shown — so the analysis may be incomplete or inaccurate and may not reflect the full technology landscape.
Nothing here is an exhaustive prior-art, novelty, freedom-to-operate or validity search, nor does it constitute legal, financial or professional advice, and it should not be relied upon as such. Verify independently and review with qualified patent and legal professionals before acting on it.
Method: Filing trend and technology composition. Derived from a Patsnap search on Bioabsorbable Fixation Implants covering 2015–2026, data cut-off 2026-07-31. Counts reflect published records only and shift as new filings publish. Every share divides by all records in scope. Data: Patsnap Eureka. See the full landscape report.